The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Two TOR Complexes, Only One of which Is Rapamycin Sensitive, Have Distinct Roles in Cell Growth Control
Open accessAbstract
The target of rapamycin (TOR) proteins in Saccharomyces cerevisiae, TOR1 and TOR2, redundantly regulate growth in a rapamycin-sensitive manner. TOR2 additionally regulates polarization of the actin cytoskeleton in a rapamycin-insensitive manner. We describe two functionally distinct TOR complexes. TOR Complex 1 (TORC1) contains TOR1 or TOR2, KOG1 (YHR186c), and LST8. TORC2 contains TOR2, AVO1 (YOL078w), AVO2 (YMR068w), AVO3 (YER093c), and LST8. FKBP-rapamycin binds TORC1, and TORC1 disruption mimics rapamycin treatment, suggesting that TORC1 mediates the rapamycin-sensitive, TOR-shared pathway. FKBP-rapamycin fails to bind TORC2, and TORC2 disruption causes an actin defect, suggesting that TORC2 mediates the rapamycin-insensitive, TOR2-unique pathway. Thus, the distinct TOR complexes account for the diversity, specificity, and selective rapamycin inhibition of TOR signaling. TORC1 and possibly TORC2 are conserved from yeast to man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“specifically, mTORC2 contains the mTOR, Rictor, LST8 and SIN1 proteins (Loewith et al., 2002).”
From Skeletal Muscle Ribosome and Mitochondrial Biogenesis in Response to Different Exercise Training Modalities (2021) · cites this paper as Loewith et al., 2002
In the citing paper
“which was discovered after it was shown that rapamycin is able to inhibit mTORC1 via binding to the protein FKBP12 (REFS31,32).”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [31]
In the citing paper
“mTOR is present in two complexes, mTORC1 (associated with ‘raptor’) and mTORC2 (associated with ‘rictor’), accounting for the diversity, specificity and selectivity of rapamycin-mediated inhibition of TOR signalling”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [31]
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M. S., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,996
Current protocols in molecular biology
Sargent, T. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90147-9 · Cited by 7,281
Sherman, F. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)94004-v · Cited by 4,078
Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051
Bähler, J., Wu, J., Longtine, M. S., Shah, N. G., Mckenzie, A., Steever, A. B., Wach, A., Philippsen, P., & Pringle, J. R. (1998) · Yeast · doi:10.1002/(sici)1097-0061(199807)14:10 · Cited by 2,208
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,010
Self-citationTOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,914
Self-citationRaptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Sujuti, H., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
The Tandem Affinity Purification (TAP) Method: A General Procedure of Protein Complex Purification
Puig, Ó., Caspary, F., Rigaut, G., Rutz, B., Bouveret, E., Bragado‐Nilsson, E., Wilm, M. S., & Séraphin, B. (2001) · Methods · doi:10.1006/meth.2001.1183 · Cited by 1,784
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
Cited by
Sorted by citations
Items 801–900 of 1,001
Liu, W., Zhao, J., Li, X., Li, Y., & Jiang, L. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00617.x · Cited by 43
Pracheil, T., Thornton, J., & Liu, Z. (2012) · Genetics · doi:10.1534/genetics.111.138305 · Cited by 43
Phosphoproteomics Reveals Resveratrol-Dependent Inhibition of Akt/mTORC1/S6K1 Signaling
Alayev, A., Doubleday, P. F., Berger, S. M., Ballif, B. A., & Holz, M. K. (2014) · Journal of Proteome Research · doi:10.1021/pr500714a · Cited by 43
Xiong, F., Dong, P., Liu, M., Xie, G., Wang, K., Zhuo, F., Feng, L., Yang, L., Li, Z., & Ren, M. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01746 · Cited by 43
Wang, G., Li, D., Miao, Z., Zhang, S., Liang, W., & Liu, L. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.10.003 · Cited by 43
Gao, N., Yao, X., Jiang, L., Yang, L., Qiu, T., Wang, Z., Pei, P., Yang, G., Liu, X., & Sun, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27318 · Cited by 43
Nuclear Functions of TOR: Impact on Transcription and the Epigenome
Laribee, R. N., & Weisman, R. (2020) · Genes · doi:10.3390/genes11060641 · Cited by 43
Jacinto, E. (2008) · IUBMB Life · doi:10.1002/iub.56 · Cited by 43
Self-citationThe Role of Targeting Mammalian Target of Rapamycin in Lung Cancer
Pal, S. K., Figlin, R. A., & Reckamp, K. L. (2008) · Clinical Lung Cancer · doi:10.3816/clc.2008.n.049 · Cited by 43
A Novel Degron-mediated Degradation of the RTG Pathway Regulator, Mks1p, by SCFGrr1
Liu, Z., Špı́rek, M., Thornton, J., & Butow, R. A. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0516 · Cited by 43
Mitophagy and mitochondrial dynamics in Saccharomyces cerevisiae
Müller, M., Lu, K., & Reichert, A. S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.02.024 · Cited by 43
Cardiovascular aging: from cellular and molecular changes to therapeutic interventions
Vakka, A., Warren, J. S., & Drosatos, K. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.09 · Cited by 44
Mafi, S., Ahmadi, E., Meehan, E. V., Chiari, C. C., Mansoori, B., Sadeghi, H., Milani, S., Jafarinia, M., Taeb, S., Bashmagh, B. M., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3032 · Cited by 43
The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas
Vemulapalli, S., Mita, A. C., Alvarado, Y., Sankhala, K. K., & Mita, M. M. (2011) · Targeted Oncology · doi:10.1007/s11523-011-0179-4 · Cited by 42
Rapley, J., Oshiro, N., Ortiz-Vega, S., & Avruch, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.245449 · Cited by 42
Petersen, J. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370273 · Cited by 42
Pib2 and the EGO complex are both required for activation of TORC1
Varlakhanova, N. V., Mihalevic, M. J., Bernstein, K. A., & Ford, M. G. J. (2017) · Journal of Cell Science · doi:10.1242/jcs.207910 · Cited by 43
The mTOR regulated RNA-binding protein LARP1 requires PABPC1 for guided mRNA interaction
Smith, E. M., Benbahouche, N. E. H., Morris, K. L., Wilczynska, A., Gillen, S. L., Schmidt, T., Meijer, H. A., Jukes‐Jones, R., Cain, K., Jones, C., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1189 · Cited by 43
Bandhakavi, S., Xie, H., O’Callaghan, B. L., Sakurai, H., Kim, D., & Griffin, T. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001598 · Cited by 42
Ravichandran, K., Zafar, I., He, Z., Doctor, R. B., Moldovan, R., Mullick, A. E., & Edelstein, C. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu208 · Cited by 42
Nutrient Control of Yeast Gametogenesis Is Mediated by TORC1, PKA and Energy Availability
Weidberg, H., Moretto, F., Spedale, G., Amon, A., & van Werven, F. J. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006075 · Cited by 42
Araki, T., Uesono, Y., Oguchi, T., & Toh‐e, A. (2005) · Genes & Genetic Systems · doi:10.1266/ggs.80.325 · Cited by 42
Amino acids-Rab1A-mTORC1 signaling controls whole-body glucose homeostasis
Zhang, X., Wang, X., Yuan, Z., Radford, S. J., Liu, C., Libutti, S. K., & Zheng, X. F. S. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108830 · Cited by 41
Rolas, L., Makhezer, N., Hadjoudj, S., Benna, J. E., Djerdjouri, B., Elkrief, L., Moreau, R., & Périanin, A. (2012) · Hepatology · doi:10.1002/hep.26109 · Cited by 41
TORC2 and the AGC kinase Gad8 regulate phosphorylation of the ribosomal protein S6 in fission yeast
Du, W., Hálová, L., Kirkham, S., Atkin, J., & Petersen, J. (2012) · Biology Open · doi:10.1242/bio.20122022 · Cited by 41
de Castro, P. A., dos Reis, T. F., Dolan, S. K., Manfiolli, A. O., Brown, N. A., Jones, G. W., Doyle, S., Riaño‐Pachón, D. M., Squina, F. M., Caldana, C., et al. (2016) · Molecular Microbiology · doi:10.1111/mmi.13484 · Cited by 43
Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells
Chen, W., Pan, Y., Wang, S., Liu, Y., Chen, G., Zhou, L., Ni, W., Wang, A., & Lu, Y. (2017) · BMC Cancer · doi:10.1186/s12885-016-3038-y · Cited by 41
Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy
Mrakovcic, M., & Fröhlich, L. F. (2019) · Cancers · doi:10.3390/cancers12010109 · Cited by 41
Rösel, D., Khurana, T., Majithia, A. R., Huang, X., Bhandari, R., & Kimmel, A. R. (2012) · Journal of Cell Science · doi:10.1242/jcs.077040 · Cited by 41
Liko, D., Conway, M. K., Grunwald, D., & Heideman, W. (2010) · Genetics · doi:10.1534/genetics.110.116665 · Cited by 43
Ando, R., Shima, H., Tamahara, T., Sato, Y., Watanabe‐Matsui, M., Kato, H., Sax, N., Motohashi, H., Taguchi, K., Yamamoto, M. P., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.661702 · Cited by 42
Wu, M., Cully, M., Andersen, D. S., & Leevers, S. J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601487 · Cited by 41
Bar‐Yosef, D. L., Cohen, A., Kupiec, M., & Weisman, R. (2015) · mBio · doi:10.1128/mbio.00959-15 · Cited by 40
Rapamycin Inhibits IGF-1 Stimulated Cell Motility through PP2A Pathway
Liu, L., Chen, L., Luo, Y., Chen, W., Zhou, H., Xu, B., Han, X., Shen, T., & Huang, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010578 · Cited by 40
Chemical Genetics of Rapamycin-Insensitive TORC2 in S. cerevisiae
Kliegman, J. I., Fiedler, D., Ryan, C. J., Xu, Y.-F., Su, X., Thomas, D. M., Caccese, M., Cheng, A., Shales, M., Rabinowitz, J. D., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.040 · Cited by 41
Sato, T., Ishii, J., Ota, Y., Sasaki, E., Shibagaki, Y., & Hattori, S. (2016) · Genes to Cells · doi:10.1111/gtc.12366 · Cited by 41
Cryo-EM insight into the structure of MTOR complex 1 and its interactions with Rheb and substrates
Chao, L. H., & Avruch, J. (2019) · F1000Research · doi:10.12688/f1000research.16109.1 · Cited by 41
Yabuki, Y., Ikeda, A., Araki, M., Kajiwara, K., Mizuta, K., & Funato, K. (2019) · Genetics · doi:10.1534/genetics.118.301874 · Cited by 40
Structural Insights into TOR Signaling
Tafur, L., Kefauver, J. M., & Loewith, R. (2020) · Genes · doi:10.3390/genes11080885 · Cited by 42
Self-citationRegulation of human mTOR complexes by DEPTOR
Wälchli, M., Berneiser, K., Mangia, F., Imseng, S., Craigie, L.-M., Stuttfeld, E., Hall, M. N., & Maier, T. (2021) · eLife · doi:10.7554/elife.70871 · Cited by 45
Self-citationAutophagy in Cancer and Chemotherapy
Yousefi, S., & Simon, H. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2008_25 · Cited by 41
Tate, J. J., Rai, R., & Cooper, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504052200 · Cited by 40
Valbuena, N., & Moreno, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011514 · Cited by 40
Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity
Sen, S., Hassane, D. C., Corbett, C. A., Becker, M. W., Jordan, C. T., & Guzmán, M. L. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.04.012 · Cited by 40
Yoneda, Y., Kuramoto, N., & Kawada, K. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104505 · Cited by 39
Molecular cloning, characterization and expression analysis of ATG1 in the silkworm, Bombyx mori
Casati, B., Terova, G., Cattaneo, A. G., Rimoldi, S., Franzetti, E., de Eguileor, M., & Tettamanti, G. (2012) · Gene · doi:10.1016/j.gene.2012.09.086 · Cited by 39
Regulation of Ribosomal RNA Production by RNA Polymerase I: Does Elongation Come First?
Albert, B., Pérez-Fernández, J., Léger‐Silvestre, I., & Gadal, O. (2012) · Genetics Research International · doi:10.1155/2012/276948 · Cited by 43
Tor Complex 1 Controls Telomere Length by Affecting the Level of Ku
Ungar, L., Harari, Y., Toren, A., & Kupiec, M. (2011) · Current Biology · doi:10.1016/j.cub.2011.11.024 · Cited by 39
Targeting mTOR in cancer: renal cell is just a beginning
Azim, H. A., Azim, H. A., & Escudier, B. J. (2010) · Targeted Oncology · doi:10.1007/s11523-010-0141-x · Cited by 40
Genome-wide expression analysis reveals TORC1-dependent and -independent functions of Sch9
Smets, B., Snijder, P. D., Engelen, K., Joossens, E., Ghillebert, R., Thevissen, K., Kathleen Marchal, D., & Winderickx, J. (2008) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2008.00432.x · Cited by 39
The inhibition of TOR in the model diatom Phaeodactylum tricornutum promotes a get-fat growth regime
Prioretti, L., Avilán, L., Carrière, F., Montané, M., Field, B., Grégori, G., Menand, B., & Gontero, B. (2017) · Algal Research · doi:10.1016/j.algal.2017.08.009 · Cited by 39
Coordination of Rheb lysosomal membrane interactions with mTORC1 activation
Angarola, B. L., & Ferguson, S. M. (2020) · F1000Research · doi:10.12688/f1000research.22367.1 · Cited by 40
Solsona, R., Pavlin, L., Bernardi, H., & Sanchez, A. M. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052741 · Cited by 42
β‐Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway
Marwarha, G., Dasari, B., Prasanthi, J. R. P., Schommer, J., & Ghribi, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06929.x · Cited by 39
Shin, C.-S., Kim, S. Y., & Huh, W. (2009) · Journal of Cell Science · doi:10.1242/jcs.047191 · Cited by 39
LST8 Regulates Cell Growth via Target-of-Rapamycin Complex 2 (TORC2)
Wang, T., Blumhagen, R. Z., Lao, U., Kuo, Y., & Edgar, B. A. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06474-11 · Cited by 39
Rehan, M. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26117 · Cited by 39
Membrane trafficking of yeast transporters: mechanisms and physiological control of downregulation
Haguenauer‐Tsapis, R., & André, B. (2004) · Topics in current genetics · doi:10.1007/b97215 · Cited by 39
Gao, Y., & Tian, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411811 · Cited by 39
PRAS40: Target or modulator of mTORC1 signalling and insulin action?
Nascimento, E. B. M., & Ouwens, D. M. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450902988580 · Cited by 39
Mechanical activation of mammalian target of rapamycin pathway is required for cartilage development
Guan, Y. A., Yang, X., Yang, W., Charbonneau, C., & Chen, Q. (2014) · The FASEB Journal · doi:10.1096/fj.14-252783 · Cited by 38
Wu, D., Chapman, J. R., Wang, L., Harris, T. E., Shabanowitz, J., Hunt, D. F., & Fu, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302117 · Cited by 38
Interaction between Rtg2p and Mks1p in the regulation of the RTG pathway of Saccharomyces cerevisiae
Ferreira-Júnior, J. R., Špı́rek, M., Liu, Z., & Butow, R. A. (2005) · Gene · doi:10.1016/j.gene.2005.03.048 · Cited by 38
Repression of glucocorticoid-stimulated angiopoietin-like 4 gene transcription by insulin
Kuo, T., Chen, T.-C., Yan, S. L., Foo, F., Ching, C., McQueen, A., & Wang, J.-C. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m047860 · Cited by 39
TORC2—a new player in genome stability
Weisman, R., Cohen, A., & Gasser, S. M. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201403959 · Cited by 38
Mammalian target of rapamycin signaling in the podocyte
Inoki, K., & Huber, T. B. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283520f38 · Cited by 38
Ang, S. Y., Hutchinson, D. S., Patil, N. A., Evans, B. A., Bathgate, R. A. D., Halls, M. L., Hossain, M. A., Summers, R. J., & Kočan, M. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13522 · Cited by 38
Zhu, C., Yin, Z., Tan, B., & Guo, W. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.023 · Cited by 38
RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity
Castel, P., Dharmaiah, S., Sale, M. J., Messing, S. A. J., Rizzuto, G. A., Cuevas-Navarro, A., Cheng, A. S., Trnka, M. J., Urisman, A., Esposito, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103261118 · Cited by 39
Banerjee, S., Gianino, S. M., Gao, F., Christians, U., & Gutmann, D. H. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0654 · Cited by 39
Devasahayam, G., Ritz, D., Helliwell, S. B., Burke, D. J., & Sturgill, T. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604303103 · Cited by 38
Genetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 37
TACC3-TSC2 maintains nuclear envelope structure and controls cell division
Gómez‐Baldó, L., Schmidt, S., Maxwell, C. A., Bonifaci, N., Gabaldón, T., Vidalain, P., Senapedis, W. T., Kletke, A., Rosing, M., Barnekow, A., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.6.11018 · Cited by 37
Glucose restriction induces transient G2 cell cycle arrest extending cellular chronological lifespan
Masuda, F., Ishii, M., Mori, A., Uehara, L., Yanagida, M., Takeda, K., & Saitoh, S. (2016) · Scientific Reports · doi:10.1038/srep19629 · Cited by 37
Bakshi, A., Moin, M., Madhav, M. S., & Kirti, P. B. (2018) · Plant Biology · doi:10.1111/plb.12935 · Cited by 37
HCMV modulation of cellular PI3K/AKT/mTOR signaling: New opportunities for therapeutic intervention?
Altman, A. M., Mahmud, J., Nikolovska‐Coleska, Z., & Chan, G. C. T. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.01.009 · Cited by 37
Duszka, K., & Wahli, W. (2020) · Nutrients · doi:10.3390/nu12113476 · Cited by 37
The TOR complex controls ATP levels to regulate actin cytoskeleton dynamics in Arabidopsis
Dai, L., Wang, B., Wang, T., Meyer, E. H., Kettel, V., Hoffmann, N., McFarlane, H. E., Li, S., Wu, X., Picard, K. L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122969119 · Cited by 37
Rheb signaling and tumorigenesis: mTORC1 and new horizons
Armijo, M. E., Campos, T., Fuentes‐Villalobos, F., Palma, M., Pincheira, R., & Castro, A. F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29707 · Cited by 38
Lee, S.-J., Feldman, R., & O’Farrell, P. H. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-03-0265 · Cited by 36
Ghosh, D., Srivastava, G. P., Xu, D. L., Schulz, L. C., & Roberts, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803182105 · Cited by 37
Hosiner, D., Lempiäinen, H., Reiter, W., Urban, J., Loewith, R., Ammerer, G., Schweyen, R. J., Shore, D., & Schüller, C. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-04-0438 · Cited by 37
Self-citationRibosomal protein S 6 phosphorylation is controlled by TOR and modulated by PKA in C andida albicans
Chowdhury, T., & Köhler, J. R. (2015) · Molecular Microbiology · doi:10.1111/mmi.13130 · Cited by 37
The Complex Genetic Basis and Multilayered Regulatory Control of Yeast Pseudohyphal Growth
Kumar, A. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-020249 · Cited by 36
Signaling Pathways Involved in Antidepressant-Induced Cell Proliferation and Synaptic Plasticity
Pilar-Cuéllar, F., Vidal, R., Díaz, Á., Castro, E., Dos-Anjos, S., Vargas, V. I., Romero, B., & Valdizán, E. M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660736 · Cited by 37
Therapy for myeloproliferative neoplasms: when, which agent, and how?
Geyer, H. L., & Mesa, R. A. (2014) · Hematology · doi:10.1182/asheducation-2014.1.277 · Cited by 36
Zhao, X., Lu, S., Nie, J., Hu, X., Luo, W., Wu, X., Liu, H., Feng, Q., Chang, Z., Liu, Y., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00144-14 · Cited by 36
Sun, J., Yin, X.-W., Liu, H.-H., Du, W.-X., Shi, L., Huang, Y., Wang, F., Liu, C., Cao, Y., & Zhang, Y. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.102 · Cited by 36
Targeting autophagy in liver cancer
Fazio, P. D., & Matrood, S. (2018) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2018.06.09 · Cited by 36
Rehan, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219180 · Cited by 36
Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities
Brodziak, A., Sobczuk, P., Bartnik, E., Fiedorowicz, M., Porta, C., Szczylik, C. A., & Czarnecka, A. M. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0233-z · Cited by 36
Nutrient Signaling and Lysosome Positioning Crosstalk Through a Multifunctional Protein, Folliculin
Garrido, N. D. M., & Aylett, C. H. S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00108 · Cited by 37
Yu, Z., Chen, J., Takagi, E., Wang, F., Saha, B., Liu, X., Joubert, L., Gleason, C. E., Jin, M., Li, C., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102288 · Cited by 39
TOR complex 2 is a master regulator of plasma membrane homeostasis
Thorner, J. W. (2022) · Biochemical Journal · doi:10.1042/bcj20220388 · Cited by 38
Pujhari, S. K., Kryworuchko, M., & Zakhartchouk, A. N. (2014) · Virus Research · doi:10.1016/j.virusres.2014.09.017 · Cited by 36
TORC2 Is Required to Maintain Genome Stability during S Phase in Fission Yeast
Schonbrun, M., Kolesnikov, M., Kupiec, M., & Weisman, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.464974 · Cited by 36
Mammalian target of rapamycin and head and neck squamous cell carcinoma
Liao, Y.-M., Kim, C., & Yen, Y. (2011) · Head & Neck Oncology · doi:10.1186/1758-3284-3-22 · Cited by 36
Weinberg, M. A. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000354 · Cited by 36
Tsang, C. K., & Zheng, X.-F. (2007) · Cell Cycle · doi:10.4161/cc.6.1.3675 · Cited by 36
Trypanosome TOR as a major regulator of cell growth and autophagy
Barquilla, A., & Navarro, M. (2009) · Autophagy · doi:10.4161/auto.5.2.7591 · Cited by 36
Metadata
- Authors
- Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N.
- Affiliations
- University of Basel (CH)
- Corresponding author
- Hall, Michael N.
- ORCID
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 10
- Issue
- 3
- Pages
- 457-468
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2152600551
- Cited by
- 1,886
- References
- 59
- Citations by year
- 2026: 37 · 2025: 47 · 2024: 68 · 2023: 65 · 2022: 75 · 2021: 79 · 2020: 70 · 2019: 76 · 2018: 76 · 2017: 100 · 2016: 68 · 2015: 115 · 2014: 97 · 2013: 103 · 2012: 135
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- TOR signaling, TOR1, TOR2, rapamycin sensitivity, cell growth regulation, LST8, Saccharomyces cerevisiae
- MeSH terms
- Actins, Animals, Antifungal Agents, Cell Line, Cytoskeleton, Fungal Proteins, Glycogen, Humans, Protein Binding, Recombinant Fusion Proteins, Saccharomyces cerevisiae, Tissue Distribution, Signal Transduction, Phosphotransferases (Alcohol Group Acceptor), Genes, Reporter, Cell Cycle Proteins, Phosphatidylinositol 3-Kinases, Sirolimus, Tacrolimus Binding Proteins, Drug Resistance, Fungal, Saccharomyces cerevisiae Proteins, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review